| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/28/2013 | US20130053436 Compounds, compositions and methods |
| 02/28/2013 | US20130053398 Modulators of fatty acid amide hydrolase |
| 02/28/2013 | US20130053386 Diaryl ether derivatives as notch sparing gamma secretase inhibitors |
| 02/28/2013 | US20130053385 Method of combating and controlling pests |
| 02/28/2013 | US20130053381 2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl-sulfonamide derivatives |
| 02/28/2013 | US20130053376 Novel tyrosine kinase inhibitors |
| 02/28/2013 | US20130053375 Amino-quinolines as kinase inhibitors |
| 02/28/2013 | US20130053372 5-ht receptor modulators |
| 02/28/2013 | US20130053364 Sulphone Compounds and Methods of Making and Using Same |
| 02/28/2013 | US20130053362 Heterocyclic compounds and uses thereof |
| 02/28/2013 | US20130053359 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING beta2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
| 02/28/2013 | US20130052281 Novel compounds |
| 02/28/2013 | US20130052138 Methods and compositions for diagnostic and therapeutic targeting of cox-2 |
| 02/28/2013 | US20130052137 Para amino benzoic acid based nanotubes |
| 02/28/2013 | US20130048971 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device |
| 02/28/2013 | US20130048964 Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Novel Organic Compound |
| 02/28/2013 | US20130048505 Plating bath and method |
| 02/28/2013 | CA2846507A1 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies |
| 02/28/2013 | CA2846122A1 Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (pde10a) in mammals |
| 02/27/2013 | EP2562175A1 5-fluoro pyrimidine derivatives as fungicides |
| 02/27/2013 | EP2562168A1 Therapeutic piperazines as PDE4 inhibitors |
| 02/27/2013 | EP2562167A1 5-fluoro pyrimidine derivatives as fungicides |
| 02/27/2013 | EP2562165A1 5-fluoro pyrimidine derivatives as fungicides |
| 02/27/2013 | EP2562161A1 5-fluoro pyrimidine derivatives as fungicides |
| 02/27/2013 | EP2562157A1 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof |
| 02/27/2013 | EP2560968A1 Polymorphic forms of lapatinib ditosylate and processes for their preparation |
| 02/27/2013 | EP2560967A1 Heterocyclic carboxylic acid amides as pdk1 inihibitors |
| 02/27/2013 | EP2560966A2 Multisubstituted aromatic compounds as inhibitors of thrombin |
| 02/27/2013 | EP2560954A2 Process of producing cycloalkylcarboxamido-indole compounds |
| 02/27/2013 | EP2560953A2 Novel inhibitors |
| 02/27/2013 | EP2560952A1 Production of atorvastatin low in lactone impurities |
| 02/27/2013 | EP2560951A1 Production of atorvastatin low in ether impurities |
| 02/27/2013 | EP2560652A2 Anti-viral compounds |
| 02/27/2013 | CN102947285A Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 02/27/2013 | CN102942561A 4-amino quinazoline heterocyclic compound and purpose of 4-amino quinazoline heterocyclic compound |
| 02/27/2013 | CN102942515A Ethane bridged indole compound, synthetic method and application thereof |
| 02/27/2013 | CN102941214A Treatment system for solid salt waste in triglycidyl isocyanurate production |
| 02/27/2013 | CN101511800B Triazolyl phenyl benzenesulfonamides |
| 02/26/2013 | US8383660 Dibenzyl amine compounds and derivatives |
| 02/26/2013 | US8383648 Applying such as 1-oxyl-4-(3'-ethoxy-2',2'-dimethyl)propanecarbonyloxy-2,2,6,6-tetramethylpiperidine to eye surface; halting growth, preventing surgery |
| 02/26/2013 | US8383638 Aminobenzoquinazolinone M1 receptor positive allosteric modulators |
| 02/26/2013 | US8383615 Azetidine 2-carboxamide derivatives which modulate the CB2 receptor |
| 02/26/2013 | CA2542076C Substituted tricyclic compounds as protein kinase inhibitors |
| 02/26/2013 | CA2523426C Aza spiro alkane derivatives as inhibitors of metalloproteases |
| 02/21/2013 | WO2013025733A1 Lysophosphatidic acid receptor antagonists |
| 02/21/2013 | WO2013025560A1 Sweet flavor modifier |
| 02/21/2013 | WO2013024898A1 Heterocyclic derivative and pharmaceutical drug |
| 02/21/2013 | WO2013024011A1 Indazole compounds, compositions and methods of use |
| 02/21/2013 | US20130046072 Aromatic monomers deriving from glycerol units, process for their preparation and use thereof for the preparation of water-soluble conjugated polymers |
| 02/21/2013 | US20130046004 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/21/2013 | US20130045974 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors |
| 02/21/2013 | US20130045973 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/21/2013 | US20130045965 Inhibitors of bruton's tyrosine kinase |
| 02/21/2013 | US20130045962 Peptide deformylase inhibitors |
| 02/21/2013 | US20130045951 Novel Nitroso Compounds as Nitroxyl Donors and Methods of Use Thereof |
| 02/21/2013 | US20130045935 Flavonoid dimers and their use |
| 02/21/2013 | US20130045914 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 02/21/2013 | CA2844982A1 Lysophosphatidic acid receptor antagonists |
| 02/21/2013 | CA2844794A1 Heterocyclic derivative and pharmaceutical |
| 02/21/2013 | CA2843499A1 Indazole compounds, compositions and methods of use |
| 02/21/2013 | CA2841012A1 Sweet flavor modifier |
| 02/20/2013 | EP2558450A1 Triazole compounds as ksp inhibitors |
| 02/20/2013 | EP2558449A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives |
| 02/20/2013 | EP2558087A1 AMIDO COMPOUNDS AS RORyt MODULATORS AND USES THEREOF |
| 02/20/2013 | CN102939287A 雌激素受体调节剂及其用途 Estrogen receptor modulators and their use |
| 02/20/2013 | CN102939284A Agent for treating hcv infection |
| 02/20/2013 | CN102939087A Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
| 02/20/2013 | CN102936241A Homopiperony lamine pyridine-2-formaldehyde and synthetic method and application thereof |
| 02/20/2013 | CN102161656B Aspartic acid-specific caspase inhibitors and uses thereof |
| 02/19/2013 | US8377983 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors |
| 02/19/2013 | CA2573371C Pyrimidines as plk inhibitors |
| 02/19/2013 | CA2508657C Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/14/2013 | WO2013022047A1 Cyclopropaneamine compound |
| 02/14/2013 | WO2013021907A1 Organic electric light emitting element, material for said element, and light emitting device, display device, and illumination device employing said element |
| 02/14/2013 | WO2013021312A1 Process for the preparation of olmesartan medoxomil |
| 02/14/2013 | WO2013021044A1 1,2,4-triazolyl-substituted keto-enols |
| 02/14/2013 | WO2013021021A1 Novel soft pde4 inhibitors |
| 02/14/2013 | WO2013020930A1 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 02/14/2013 | US20130041046 Sweet flavor modifier |
| 02/14/2013 | US20130041008 Compounds for enzyme inhibition |
| 02/14/2013 | US20130041005 Pharmaceutical compositions comprising neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers |
| 02/14/2013 | US20130040993 Fungicide hydroximoyl-heterocycles derivatives |
| 02/14/2013 | US20130040992 Substituted 2, 6-Diamino-3, 5-Dicyano-4-Aryl-Pyridines And Their Use As Adenosine-Receptor-Selective Ligands |
| 02/14/2013 | US20130040977 Pro-Neurogenic Compounds |
| 02/14/2013 | US20130040975 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/14/2013 | US20130040962 P38 MAP Kinase Inhibitors |
| 02/14/2013 | US20130040951 Prophylactic or therapeutic agent for cancer |
| 02/14/2013 | US20130040950 Multisubstituted aromatic compounds as inhibitors of thrombin |
| 02/14/2013 | US20130040948 Novel benzodioxole piperazine compounds |
| 02/14/2013 | US20130040947 Trkb agonists and methods of use |
| 02/14/2013 | US20130040945 Certain chemical entities, compositions, and methods |
| 02/14/2013 | US20130040944 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 02/14/2013 | US20130040941 Benzodiazepine compound and pharmaceutical composition |
| 02/14/2013 | US20130040931 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use |
| 02/14/2013 | US20130040928 Nitrogen heterocycle derivatives, preparation thereof and application thereof in human therapeutics |
| 02/14/2013 | US20130040916 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses |
| 02/14/2013 | US20130040907 Compounds, Compositions and Methods of Using Same for Modulating Uric Acid Levels |
| 02/14/2013 | US20130040389 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex |
| 02/14/2013 | CA2855948A1 1,2,4-triazolyl-substituted keto-enols |
| 02/14/2013 | CA2844525A1 Cyclopropaneamine compound |